Trypanosoma cruzi is a parasitic hemoflagellate and is the causative agent of Chagas Disease. This parasitic disease constitutes a major human health hazard in South and Central America, and, thus far, no successful chemotherapeutic cure or immunoprophylactic methods to prevent infection have been developed. Since both man and experimental animals can developed acquired resistance against acute infections of T. cruzi, the development of an effective vaccine for prevention and control of the disease should be feasible. This approach which we have taken for the development of a vaccine against this parasite focuses on the surface antigens of the infective form of the parasite. The rationale for this approach is based on the knowledge that interiorization of the parasite into the host cell is essential for establishing infection. The penetration process is a membrane-mediated phenomenon which likely involves parasite surface proteins. In accord with this line of reasoning, host cell penetration has been shown to involve at least one trypomastigote specific surface antigen of Mr 85, and are currently engaged in producing two of these antigens in amounts sufficient for immunization trials. In continuing these studies, the experiments that I propose for the next granting period are: (1) To test the ability of the 85, 90 and 34-41 kDa trypomastigote specific surface proteins to confer protective immunity to mice against an otherwise lethal inoculum of T. cruzi; (2) To determine whether the extent of antigenic diversity in the 85 kDa gene family among different clonal isolates of the parasite is sufficient to influence vaccine design; (3) To examine the possibility that spontaneous antigenic variation similar to that found in the African trypanosome occurs within the 85 kDa gene family in T. cruzi; (4) If substantial variation and/or diversity does occur within this gene family, we will determine whether constant and variable regions occur within the different expressed members of the gene family which might be exploited for vaccine design; (5) To continue work on the isolation, characterization and expression of the 34-41 kDa surface protein gene for subsequent immunization trials.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018873-09
Application #
3128265
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1982-04-01
Project End
1995-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Hardison, Jenny L; Wrightsman, Ruth A; Carpenter, Philip M et al. (2006) The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74:135-43
Hardison, Jenny L; Wrightsman, Ruth A; Carpenter, Philip M et al. (2006) The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74:125-34
Hardison, Jenny L; Kuziel, William A; Manning, Jerry E et al. (2006) Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. J Infect Dis 193:1584-8
Wrightsman, Ruth A; Luhrs, Keith A; Fouts, David et al. (2002) Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells. Parasite Immunol 24:401-12
Wrightsman, R A; Manning, J E (2000) Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi. Vaccine 18:1419-27
Giordano, R; Fouts, D L; Tewari, D et al. (1999) Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J Biol Chem 274:3461-8
Quanquin, N M; Galaviz, C; Fouts, D L et al. (1999) Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity. Infect Immun 67:4603-12
Fouts, D L; Stryker, G A; Gorski, K S et al. (1998) Evidence for four distinct major protein components in the paraflagellar rod of Trypanosoma cruzi. J Biol Chem 273:21846-55
Miller, M J; Wrightsman, R A; Stryker, G A et al. (1997) Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. J Immunol 158:5330-7
Miller, M J; Wrightsman, R A; Manning, J E (1996) Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp Parasitol 84:156-67

Showing the most recent 10 out of 23 publications